Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 2/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.32 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | LTA4H | P09960 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 4/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3889075 | 0.79 | CA4 (0.38) | CA4ESR1ESR2POLBCA12 | |
| SCHEMBL646249 | 0.75 | CA4 (0.43) | CA4ESR1ESR2POLBCA12 | |
| Methylamine SCHEMBL28410618 | 0.74 | POLB (0.38) | CA4ESR1ESR2POLBCA12 | |
| SCHEMBL3891704 | 0.73 | ALDH1A1 (0.34) | ESR1ESR2ALDH1A1LTA4HTSHR | |
| SCHEMBL948687 | 0.73 | ALDH1A1 (0.33) | ESR1ESR2ALDH1A1PTGS1TSHR | |
| SCHEMBL648335 | 0.72 | CA4 (0.41) | CA4ESR1ESR2POLBCA12 | |
| SCHEMBL37986 | 0.72 | CA4 (0.41) | CA4ESR1ESR2POLBCA12 | |
| SCHEMBL49008 | 0.72 | CA4 (0.41) | CA4ESR1ESR2POLBCA12 | |
| SCHEMBL49088 | 0.72 | CA4 (0.41) | CA4ESR1ESR2POLBCA12 | |
| SCHEMBL27596877 | 0.72 | CA4 (0.41) | CA4ESR1ESR2POLBCA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 180 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109439260-A | A kind of trickling type silane modified polyether transparent adhesive tape and preparation method thereof | 成都硅宝新材料有限公司 | 2019-03-08 | — | — | CN | claimed |
| CN-107880837-A | Exfoliated silane modified polyether adhesive of shock resistance and preparation method thereof | 广州市白云化工实业有限公司 | 2018-04-06 | — | — | CN | claimed |
| CN-107189745-A | Environment-friendly type silane modified polyether coating glue and preparation method thereof | 广州市白云化工实业有限公司 | 2017-09-22 | — | — | CN | claimed |
| CN-104629666-A | Silylation-terminated polyether adhesive and preparation method thereof | GUANGDONG XINZHAN NEW CHEMICAL MATERIAL CO LTD | 2015-05-20 | — | — | CN | claimed |
| CN-104610900-A | Nail-free glue and preparation method thereof | GUANGDONG XINZHAN NEW CHEMICAL MATERIAL CO LTD | 2015-05-13 | — | — | CN | claimed |
| CN-104087229-A | Acrylic resin modified silane-terminated polyether sealant and preparation method thereof | GUANGZHOU XINZHAN NEW CHEMICAL MATERIAL CO LTD | 2014-10-08 | — | — | CN | claimed |
| CN-104087238-A | Antifouling sealing material and preparation method thereof | GUANGZHOU XINZHAN NEW CHEMICAL MATERIAL CO LTD | 2014-10-08 | — | — | CN | claimed |
| CN-104087228-A | Low-modulus silyl-terminated modified polyether sealant and preparation method thereof | GUANGZHOU XINZHAN NEW CHEMICAL MATERIAL CO LTD | 2014-10-08 | — | — | CN | claimed |
| CN-104087226-A | Modified polyether sealant and preparation method thereof | GUANGZHOU XINZHAN NEW CHEMICAL MATERIAL CO LTD | 2014-10-08 | — | — | CN | claimed |
| WO-1999063003-A1 | LOW-OUTGASSING, ROOM TEMPERATURE VULCANIZING SILICONE COMPOSITIONS | LOCTITE CORPORATION (US) | 1999-12-09 | — | — | WO | claimed |
| US-20260048880-A1 | HIGH EFFICIENCY PHARMACEUTICAL FILLING LINE | CORNING INC (US) | 2026-02-19 | — | — | US | disclosed |
| EP-3959180-B1 | PHARMACEUTICAL PACKAGES WITH COATINGS COMPRISING POLYSILAZANE | CORNING INC (US) | 2025-10-15 | — | — | EP | disclosed |
| US-12409103-B2 | Glass articles with low-friction coatings | CORNING INCORPORATED (US) | 2025-09-09 | — | — | US | disclosed |
| US-12391600-B2 | Delamination resistant glass containers with heat-tolerant coatings | CORNING INCORPORATED (US) | 2025-08-19 | — | — | US | disclosed |
| US-12365498-B2 | High efficiency pharmaceutical filling line | CORNING INCORPORATED (US) | 2025-07-22 | — | — | US | disclosed |
| US-20050044778-A1 | Fuel compositions employing catalyst combustion structure | OCTANE INTERNATIONAL, LTD. | 2005-03-03 | — | — | US | disclosed |
| US-20040237384-A1 | Fuel compositions exhibiting improved fuel stability | OCTANE INTERNATIONAL, LTD. | 2004-12-02 | — | — | US | disclosed |
| WO-1999063003-A1 | LOW-OUTGASSING, ROOM TEMPERATURE VULCANIZING SILICONE COMPOSITIONS | LOCTITE CORPORATION (US) | 1999-12-09 | — | — | WO | disclosed |
| EP-0954558-A1 | FUEL COMPOSITIONS EXHIBITING IMPROVED FUEL STABILITY | ORR, William C. (US) | 1999-11-10 | — | — | EP | disclosed |
| WO-1998026028-A1 | FUEL COMPOSITIONS EXHIBITING IMPROVED FUEL STABILITY | ORR WILLIAM C (US) | 1998-06-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260048880-A1 | HIGH EFFICIENCY PHARMACEUTICAL FILLING LINE | HTR2B, P2RY10, P2RX4 | CA4 3594/4885ESR1 3318/4885ESR2 3648/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.